ClinicalTrials.gg
Not yet recruitingNCT07847996MED-SWAPUpdated Sep 29, 2026

Replacing Meat With Legumes in a Mediterranean Diet

An interventional study of Mediterranean Diet With Grass-Fed Organic Meat and Mediterranean Diet With Legumes in Healthy Adult Participants, sponsored by Universidad Francisco de Vitoria. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Universidad Francisco de Vitoria · Not applicable, Interventional, and Prevention

How we know

Updated Sep 29, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study will investigate whether replacing grass-fed organic meat with legumes within a Mediterranean diet affects cardiometabolic health in healthy adults. Participants will be randomly assigned to follow a Mediterranean diet that includes either grass-fed organic meat or legumes as the main protein source for 8 weeks. The study will compare changes in blood cholesterol, blood glucose, inflammation, blood pressure, and other health measures between the two groups. The main outcome will be the change in LDL cholesterol, a type of cholesterol associated with cardiovascular health. The study will include healthy adults aged 25 to 65 years living in the Community of Madrid, Spain.

Read the detailed description

The Mediterranean diet is a dietary pattern associated with cardiovascular health and is characterized by a high consumption of plant foods, including vegetables, fruits, whole grains, legumes, nuts, and olive oil. Within this dietary pattern, different combinations of animal- and plant-based protein sources can be used while maintaining the overall characteristics of the diet.

Legumes provide protein, dietary fiber, resistant starch, phytosterols, and phenolic compounds, which may influence lipid and glucose metabolism. Meat provides high-quality protein and highly bioavailable micronutrients, while its nutritional composition may vary according to the production system. In particular, meat from pasture-fed animals may differ in fatty acid composition and other nutritional characteristics from meat produced using conventional intensive systems.

Previous studies have investigated the effects of replacing meat with legumes on cardiometabolic health. However, much of the available evidence has evaluated conventional meat sources or has compared broader dietary patterns rather than specifically examining the replacement of grass-fed organic meat with legumes while maintaining a Mediterranean dietary pattern. Therefore, the cardiometabolic effects of this specific dietary substitution remain insufficiently characterized.

The MED-SWAP study is a randomized, controlled, parallel-group clinical trial designed to investigate the effects of replacing grass-fed organic meat with legumes within a Mediterranean diet. Participants will be randomly assigned to one of two dietary interventions for 8 weeks. Both groups will follow a structured Mediterranean dietary pattern, with the main systematic difference being the principal protein source.

The control group will follow a Mediterranean diet including grass-fed organic meat, consisting of at least four servings per week of a mixture of red and white meat, while limiting legumes as a main dish to a maximum of one serving per week. The intervention group will follow a Mediterranean diet including legumes, with at least four servings per week of legumes such as lentils, chickpeas, beans, or traditional soy, while limiting grass-fed organic meat to a maximum of one serving per week.

The replacement of meat with legumes will be designed to be isocaloric, with the aim of maintaining comparable total energy intake and the overall macronutrient distribution between groups. The remaining components of the Mediterranean dietary pattern will be structured similarly in both groups. Participants will receive structured menus, standard serving sizes, and food equivalences to facilitate adherence and standardization.

Dietary adherence will be monitored throughout the intervention using periodic 3-day dietary records, including one weekend day, 24-hour dietary recalls, and regular contacts with a dietitian-nutritionist. Adherence to the prescribed weekly servings of the main protein source will also be assessed during follow-up visits. Participants who show inadequate adherence will receive individualized dietary reinforcement and will remain in the study whenever possible.

The study will evaluate whether this specific modification of the protein sources within a Mediterranean dietary pattern is associated with differences in cardiometabolic biomarkers after the 8-week intervention. The primary outcome is the change in LDL cholesterol. Secondary assessments include other lipid parameters, glucose metabolism, inflammatory markers, blood pressure, anthropometric measures, and the neutrophil-to-lymphocyte ratio.

The study will provide clinical evidence on the effects of modifying the relative contribution of animal and plant protein sources within a Mediterranean dietary pattern, with particular emphasis on the substitution of grass-fed organic meat with legumes. The findings may contribute to a better understanding of how specific food substitutions within an established healthy dietary pattern relate to cardiometabolic health.

02

Conditions studied

  • Healthy Adult Participants

Keywords

  • legumes
  • meat
  • mediterranean diet
  • plant-based diet
  • cardiometabolic health
03

In context

Lead sponsor

Universidad Francisco de Vitoria is the lead sponsor of 54 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-65 years.
  • (BMI) 18.5-29.9 kg/m².
  • No previous diagnosis of cardiovascular disease, diabetes mellitus, kidney disease, or chronic inflammatory disease.
  • Habitual consumption of meat and willingness to follow the assigned dietary intervention.
  • No vegetarian or vegan diet during the previous 6 months.
  • Ability to provide written .

Exclusion criteria

Exclusion Criteria:

  • Use of lipid-lowering, antihypertensive, or antidiabetic medication.
  • Pregnancy or breastfeeding.
  • Allergy or intolerance to legumes or meat.
  • Significant gastrointestinal disorders.
  • No tobacco use.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Mediterranean Diet With Grass-Fed Organic Meat

    Participants assigned to this arm will follow a structured Mediterranean diet for 8 weeks, including at least four servings per week of grass-fed organic meat, consisting of a mixture of red and white meat. Consumption of legumes as a main dish will be limited to a maximum of one serving per week. The diet will also include the common components of the Mediterranean dietary pattern, including fruits, vegetables, whole grains, nuts, and extra virgin olive oil as the main culinary fat, as well as regular fish consumption. The dietary intervention will be designed to maintain comparable energy intake and overall macronutrient distribution between study groups. Participants will receive structured menus, standard serving sizes, and food equivalences, with dietary adherence monitored throughout the intervention by a dietitian-nutritionist.

    Behavioral: Mediterranean Diet With Grass-Fed Organic Meat

  • Experimental
    Mediterranean Diet With Legumes

    Participants assigned to this arm will follow a structured Mediterranean diet for 8 weeks, including at least four servings per week of legumes, such as lentils, chickpeas, beans, or traditional soy. Consumption of meat will be limited to a maximum of one serving per week. The diet will also include the common components of the Mediterranean dietary pattern, including fruits, vegetables, whole grains, nuts, and extra virgin olive oil as the main culinary fat, as well as regular fish consumption. The dietary intervention will be designed to maintain comparable energy intake and overall macronutrient distribution between study groups. Participants will receive structured menus, standard serving sizes, and food equivalences, with dietary adherence monitored throughout the intervention by a dietitian-nutritionist.

    Behavioral: Mediterranean Diet With Legumes

Interventions

  • BehavioralMediterranean Diet With Grass-Fed Organic Meat

    Participants assigned to this arm will follow a structured Mediterranean diet for 8 weeks, including at least four servings per week of grass-fed organic meat, consisting of a mixture of red and white meat. Consumption of legumes as a main dish will be limited to a maximum of one serving per week. The diet will also include the common components of the Mediterranean dietary pattern, including fruits, vegetables, whole grains, nuts, and extra virgin olive oil as the main culinary fat, as well as regular fish consumption. The dietary intervention will be designed to maintain comparable energy intake and overall macronutrient distribution between study groups. Participants will receive structured menus, standard serving sizes, and food equivalences, with dietary adherence monitored throughout the intervention by a dietitian-nutritionist.

  • BehavioralMediterranean Diet With Legumes

    Participants assigned to this arm will follow a structured Mediterranean diet for 8 weeks, including at least four servings per week of legumes, such as lentils, chickpeas, beans, or traditional soy. Consumption of meat will be limited to a maximum of one serving per week. The diet will also include the common components of the Mediterranean dietary pattern, including fruits, vegetables, whole grains, nuts, and extra virgin olive oil as the main culinary fat, as well as regular fish consumption. The dietary intervention will be designed to maintain comparable energy intake and overall macronutrient distribution between study groups. Participants will receive structured menus, standard serving sizes, and food equivalences, with dietary adherence monitored throughout the intervention by a dietitian-nutritionist.

06

What researchers measure

Primary outcomes

  1. Change in LDL Cholesterol (LDL-C)

    Change in LDL cholesterol from baseline to week 8, measured in mg/dL. The effect of the intervention will be assessed by comparing the change in LDL cholesterol between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

Secondary outcomes

  1. Change in HDL Cholesterol (HDL-C)

    Change in HDL cholesterol from baseline to week 8, measured in mg/dL. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  2. Change in Triglycerides

    Change in blood triglyceride concentration from baseline to week 8, measured in mg/dL. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  3. Change in Fasting Blood Glucose

    Change in fasting blood glucose from baseline to week 8, measured in mg/dL. Blood samples will be collected after an overnight fast. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  4. Change in Fasting Insulin

    Change in fasting insulin concentration from baseline to week 8, measured in appropriate laboratory units. Blood samples will be collected after an overnight fast. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  5. Change in HOMA-IR

    Change in the homeostatic model assessment of insulin resistance (HOMA-IR) from baseline to week 8. HOMA-IR will be calculated from fasting glucose and fasting insulin measurements. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  6. Change in High-Sensitivity C-Reactive Protein

    Change in high-sensitivity C-reactive protein (hs-CRP) concentration from baseline to week 8, measured in mg/L. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  7. Change in Neutrophil-to-Lymphocyte Ratio

    Change in the neutrophil-to-lymphocyte ratio (NLR) from baseline to week 8. NLR will be calculated from neutrophil and lymphocyte counts obtained from the complete blood count. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  8. Change in Body Mass Index

    Change in body mass index (BMI) from baseline to week 8, calculated as body weight in kilograms divided by height in meters squared (kg/m²). The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  9. Change in Waist Circumference

    Change in waist circumference from baseline to week 8, measured in centimeters. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  10. Change in Systolic Blood Pressure

    Change in systolic blood pressure from baseline to week 8, measured in mmHg. Blood pressure will be assessed using the mean of three measurements. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  11. Change in Diastolic Blood Pressure

    Change in diastolic blood pressure from baseline to week 8, measured in mmHg. Blood pressure will be assessed using the mean of three measurements. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  12. Change in Total Testosterone

    Change in total testosterone concentration from baseline to week 8, measured in appropriate laboratory units. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  13. Change in Serum Cortisol

    Change in serum cortisol concentration from baseline to week 8, measured in appropriate laboratory units. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  14. Change in Serum Iron

    Change in serum iron concentration from baseline to week 8, measured in appropriate laboratory units. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  15. Change in Serum Ferritin

    Change in serum ferritin concentration from baseline to week 8, measured in appropriate laboratory units. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  16. Change in Serum Transferrin

    Change in serum transferrin concentration from baseline to week 8, measured in appropriate laboratory units. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  17. Change in Insulin-Like Growth Factor 1

    Change in insulin-like growth factor 1 (IGF-1) concentration from baseline to week 8, measured in appropriate laboratory units. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  18. Change in Hemoglobin A1c

    Change in hemoglobin A1c (HbA1c) from baseline to week 8, measured as a percentage. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  19. Change in Apolipoprotein B

    Change in apolipoprotein B (ApoB) concentration from baseline to week 8, measured in appropriate laboratory units. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  20. Change in Apolipoprotein A-I

    Change in apolipoprotein A-I (ApoA-I) concentration from baseline to week 8, measured in appropriate laboratory units. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  21. Lipoprotein(a)

    Baseline concentration of lipoprotein(a) \[Lp(a)\], measured in appropriate laboratory units before the dietary intervention.

    Time frame: Baseline

  22. Change in Fat Mass

    Change in total fat mass from baseline to week 8, measured in kilograms. Body composition will be assessed at baseline and week 8 using the study's standardized body composition assessment method. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  23. Change in Fat-Free Mass

    Change in fat-free mass from baseline to week 8, measured in kilograms. Body composition will be assessed at baseline and week 8 using the study's standardized body composition assessment method. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

  24. Change in Body Fat Percentage

    Change in body fat percentage from baseline to week 8, expressed as a percentage. Body composition will be assessed at baseline and week 8 using the study's standardized body composition assessment method. The change will be compared between the Mediterranean Diet With Legumes group and the Mediterranean Diet With Grass-Fed Organic Meat group.

    Time frame: Baseline to Week 8

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — No individual participant data-sharing plan has been established for this study. Results will be reported and shared in aggregate form through scientific publications and other dissemination activities.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2026
First posted
Sep 29, 2026
StartEst.
Oct 13, 2026
Primary completionEst.
Dec 14, 2026
CompletionEst.
Dec 14, 2026
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07847996
Lead sponsor
Universidad Francisco de Vitoria
Responsible party
Miguel López Moreno (Principal Investigator, Universidad Francisco de Vitoria) — Principal investigator
First posted
Sep 29, 2026
Start date
Oct 13, 2026 (estimated)
Primary completion
Dec 14, 2026 (estimated)
Completion
Dec 14, 2026 (estimated)
Last update
Sep 29, 2026

Study contacts

Miguel López Moreno, PhD
Contact
miguel.lopez@ufv.es
+34647892334

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion